Thrombocythemia and coronary artery disease.

Suppr

超能文献

作者信息

Scheffer M G, Michiels J J, Simoons M L, Roelandt J R

机构信息

Thoraxcenter, Department of Cardiology, Erasmus University Rotterdam, The Netherlands.

出版信息

Am Heart J. 1991 Aug;122(2):573-6. doi: 10.1016/0002-8703(91)91019-j.

DOI:10.1016/0002-8703(91)91019-j

PMID:1858644

Abstract

摘要

相似文献

Thrombocythemia and coronary artery disease.

Am Heart J. 1991 Aug;122(2):573-6. doi: 10.1016/0002-8703(91)91019-j.

Prevention of thrombosis in polycythemia vera and essential thrombocythemia.真性红细胞增多症和原发性血小板增多症中血栓形成的预防。

Haematologica. 2008 Mar;93(3):331-5. doi: 10.3324/haematol.12604.

Busulfan versus hydroxyurea in the treatment of polycythemia vera (PV) and essential thrombocythemia (ET).白消安与羟基脲治疗真性红细胞增多症（PV）和原发性血小板增多症（ET）的对比

Am J Clin Oncol. 1998 Feb;21(1):105-6. doi: 10.1097/00000421-199802000-00024.

Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.阿司匹林用于控制原发性血小板增多症和真性红细胞增多症中的血小板活化及预防血栓形成：当前见解及未来研究的理论依据

Semin Thromb Hemost. 2006 Apr;32(3):251-9. doi: 10.1055/s-2006-939436.

Primary thrombocythemia.原发性血小板增多症

Geriatrics. 1973 Jan;28(1):121-33.

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.对于不耐受或抵抗羟基脲的真性红细胞增多症或原发性血小板增多症患者，使用白消安治疗。

Ann Hematol. 2014 Dec;93(12):2037-43. doi: 10.1007/s00277-014-2152-7. Epub 2014 Jul 2.

[Essential thrombocythemia: conventional therapy].[原发性血小板增多症：传统疗法]

Haematologica. 1991 Jun;76 Suppl 3:368-70.

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.真性红细胞增多症和原发性血小板增多症患者的复发性血栓形成：发病率、危险因素及治疗效果。

Haematologica. 2008 Mar;93(3):372-80. doi: 10.3324/haematol.12053. Epub 2008 Feb 11.

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.对曾有内脏静脉血栓形成的真性红细胞增多症和原发性血小板增多症患者进行聚乙二醇化干扰素α-2a治疗的前瞻性评估。

Leukemia. 2019 Dec;33(12):2974-2978. doi: 10.1038/s41375-019-0524-7. Epub 2019 Jul 30.

High red blood cell distribution width might predict thrombosis in essential thrombocythemia and polycythemia vera.高红细胞分布宽度可能预测原发性血小板增多症和真性红细胞增多症中的血栓形成。

Blood Cells Mol Dis. 2020 Feb;80:102368. doi: 10.1016/j.bcmd.2019.102368. Epub 2019 Oct 21.

引用本文的文献

Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist.原发性血小板增多症：心脏病专家相关的诊断、鉴别诊断、并发症及治疗考量

Neth Heart J. 2023 Oct;31(10):371-378. doi: 10.1007/s12471-023-01757-4. Epub 2023 Feb 9.

Essential Thrombocytosis in Patients <40 Years Old With Acute Coronary Syndromes: A Not So Uncommon Underlying Diagnosis Often Overlooked.40岁以下急性冠脉综合征患者的原发性血小板增多症：一种常被忽视但并不罕见的潜在诊断。

Cureus. 2022 Dec 17;14(12):e32638. doi: 10.7759/cureus.32638. eCollection 2022 Dec.

Immune-based therapies in cardiovascular and metabolic diseases: past, present and future.免疫疗法在心血管和代谢疾病中的应用：过去、现在和未来。

Nat Rev Immunol. 2021 Oct;21(10):669-679. doi: 10.1038/s41577-021-00580-5. Epub 2021 Jul 20.

Disordered haematopoiesis and athero-thrombosis.造血功能紊乱与动脉粥样硬化血栓形成。

Eur Heart J. 2016 Apr 7;37(14):1113-21. doi: 10.1093/eurheartj/ehv718. Epub 2016 Feb 10.

Long-term risk of acute coronary syndrome in splenectomized patients due to splenic injury.脾损伤所致脾切除患者发生急性冠状动脉综合征的长期风险。

Medicine (Baltimore). 2015 Mar;94(9):e610. doi: 10.1097/MD.0000000000000610.

Off-pump myocardial revascularization in a high-risk patient with essential thrombocythemia.原发性血小板增多症高危患者的非体外循环下心肌血运重建术

Tex Heart Inst J. 2014 Oct 1;41(5):537-42. doi: 10.14503/THIJ-13-3508. eCollection 2014 Oct.

Coronary spasm-related acute myocardial infarction in a patient with essential thrombocythemia.

World J Cardiol. 2011 Aug 26;3(8):278-80. doi: 10.4330/wjc.v3.i8.278.

Coronary vasculopathy in polycythemia vera.真性红细胞增多症中的冠状动脉血管病变。

Pathol Oncol Res. 1998;4(1):37-9. doi: 10.1007/BF02904693.

Primary thrombocythemia: diagnosis, clinical manifestations and management.

Ann Hematol. 1993 Aug;67(2):57-62. doi: 10.1007/BF01788127.

Familial essential thrombocythemia: clinical characteristics of 11 cases in one family.家族性原发性血小板增多症：一个家族中11例患者的临床特征

Ann Hematol. 1994 Mar;68(3):153-8. doi: 10.1007/BF01727421.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验